ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Effient (prasugrel) by Year
Effient (prasugrel) — Worldwide revenue ($M) [legacy separate disclosure] ($M)
Eli Lilly Effient (prasugrel): $122M in FY2018, down 68.6% from a year earlier. No newer figure appears in the documents we track.
Where the FY2018 figure comes from
Source: Form 10-K (filed 2019-02-19) ↗
Reported in Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Effient (prasugrel) — Worldwide revenue ($M) [legacy separate disclosure] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2018 | Dec 31, 2018 | 122 | -68.6% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 389 | -27.3% | Form 10-K (filed 2019-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 535 | +2.3% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 523 | +0.2% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 522 | +2.7% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 509 | +11.3% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 457 | +51.1% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 303 | +163.0% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 115 | +325.9% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 27 | – | Form 10-K (filed 2011-02-22) ↗ |
Breakdown
What makes up effient (prasugrel)
Cite this data
StockData. (2026). Eli Lilly Effient (prasugrel) ($M), annual FY2009–FY2018 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-effient-ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.